(PubMed) Lahner E, Persechino S, Annibale B
It is not approved for human or veterinary use by the FDA or any other regulatory agency
A 2017 study by Hsieh and colleagues in Journal of Molecular Medicine reported that BPC-157, in chick chorioallantoic membrane, rat hind-limb ischemia, and HUVEC models, directionally increased vessel density, accelerated blood-flow recovery in ischemic muscle, and time-dependently activated the VEGFR2-Akt-eNOS signaling pathway via VEGFR2 internalization a mechanistic preclinical finding for which numeric effect sizes are not reported in the abstract
The actual benefit is narrower and more honest: correcting an existing deficiency can restore energy levels and general well being, which indirectly supports a healthy weight through better activity and mood, not through a direct metabolic effect
Always follow the dosage instructions provided by your healthcare provider